GLP1R and type 2 diabetes mellitus: Barriers to accessing care, less patient-centered interactions by practitioners, and biases in care delivery have been well-documented among Asian patients and likely play a role in the inequitable use of GLP-1 RA in this population.30,31 Among patients with T2D, Asian patients have the lowest body mass index compared with other races and ethnicities,32 a difference that may influence prescribing practices.